What is Krabeva?

Krabeva is a medication that helps treat cancer by blocking a protein called vascular endothelial growth factor (VEGF). This protein is important for forming new blood vessels that supply nutrients to tumors. By stopping VEGF, Krabeva can help in slow down tumor growth and prevent the spread of cancer.

When is Krabeva Used?

Krabeva is commonly used for various types of cancer, including:
- Metastatic Colorectal Cancer
- Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Advanced Renal Cell Carcinoma (kidney cancer)
- Glioblastoma (a type of brain cancer)
- Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Cervical Cancer (when used with other chemotherapy medications)

How is Krabeva Given?

Form: Krabeva is administered through an IV (intravenous infusion).
Recommended Dosing schedule, the actual may be customised basis your requirement by your treating doctor
For Metastatic Colorectal Cancer:
- 5 mg/kg or 10 mg/kg every 2 weeks
- or 7.5 mg/kg or 15 mg/kg every 3 weeks
For Non-Small Cell Lung Cancer:
- 7.5 mg/kg or 15 mg/kg every 3 weeks (with platinum-based chemotherapy)
For Renal Cell Carcinoma:
- 10 mg/kg every 2 weeks (with interferon alpha)
For Glioblastoma:
- 10 mg/kg every 2 weeks
- or 15 mg/kg every 3 weeks
For Epithelial Ovarian Cancer:
- 15 mg/kg every 3 weeks (if sensitive to platinum)
- or 10 mg/kg every 2 weeks (if resistant to platinum)
For Cervical Cancer:
- 15 mg/kg every 3 weeks (with paclitaxel and cisplatin or topotecan)

Important Notes:

- Your healthcare team will determine the best dosage and schedule based on your specific situation.
- They will monitor you during treatment to ensure safety and effectiveness.
- If you have any questions or concerns, please talk to your healthcare provider!